Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: UBS Upgrades RBS To Buy From Neutral

Tue, 21st Apr 2020 09:36

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

LIBERUM RAISES CRODA INTERNATIONAL TO 'BUY' ('HOLD') - TARGET 5100 (4700) PENCE

----------

UBS RAISES RBS TO 'BUY' ('NEUTRAL') - PRICE TARGET 150 (215) PENCE

----------

GOLDMAN SACHS CUTS BHP GROUP PRICE TARGET TO 1680 (1700) PENCE - 'BUY'

----------

RBC CUTS LAND SECURITIES PRICE TARGET TO 825 (1100) PENCE - 'OUTPERFORM'

----------

RBC CUTS BRITISH LAND PRICE TARGET TO 455 (575) PENCE - 'SECTOR PERFORM'

----------

KEPLER CHEUVREUX RAISES ASTRAZENECA PRICE TARGET TO 8300 (7700) PENCE - 'BUY'

----------

JPMORGAN CUTS ST JAMES'S PLACE PRICE TARGET TO 937 (1325) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS PRUDENTIAL PRICE TARGET TO 1031 (1425) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS PHOENIX GROUP PRICE TARGET TO 786 (904) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS LEGAL & GENERAL PRICE TARGET TO 200 (284) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS AVIVA PRICE TARGET TO 332 (498) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS BP PRICE TARGET TO 425 (475) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS ROYAL DUTCH SHELL A PRICE TARGET TO 1650 (1750) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS SHELL B PRICE TARGET TO 1650 (1750) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS TAYLOR WIMPEY PRICE TARGET TO 186 (206) PENCE - 'BUY'

----------

JEFFERIES CUTS PERSIMMON PRICE TARGET TO 3245 (3531) PENCE - 'BUY'

----------

JEFFERIES CUTS BERKELEY GROUP PRICE TARGET TO 5727 (5779) PENCE - 'BUY'

----------

JEFFERIES CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 659 (729) PENCE - 'BUY'

----------

GOLDMAN CUTS PEARSON PRICE TARGET TO 625.2 (658) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

GOLDMAN CUTS CAPITA TO 'BUY' ('CONVICTION BUY LIST') - TARGET 70 (200) PENCE

----------

BANK OF AMERICA INITIATES INVESTEC WITH 'BUY' - PRICE TARGET 190 PENCE

----------

LIBERUM CUTS BIG YELLOW GROUP PRICE TARGET TO 1000 (1100) PENCE - 'HOLD'

----------

RBC CUTS GREAT PORTLAND PRICE TARGET TO 550 (600) PENCE - 'UNDERPERFORM'

----------

RBC CUTS DERWENT LONDON PRICE TARGET TO 2750 (2900) PENCE - 'UNDERPERFORM'

----------

JPMORGAN CUTS JUST GROUP PRICE TARGET TO 59 (79) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS MITCHELLS & BUTLERS PRICE TARGET TO 400 (530) PENCE - 'BUY'

----------

JEFFERIES CUTS MARSTONS PRICE TARGET TO 35 (90) PENCE - 'UNDERPERFORM'

----------

JEFFERIES RAISES JD WETHERSPOON TO 'BUY' ('HOLD') - TARGET 1150 (1590) PENCE

----------

JEFFERIES CUTS REDROW PRICE TARGET TO 697 (809) PENCE - 'BUY'

----------

JEFFERIES CUTS CREST NICHOLSON PRICE TARGET TO 331 (362) PENCE - 'BUY'

----------

JEFFERIES CUTS COUNTRYSIDE PROPERTIES PRICE TARGET TO 587 (606) PENCE - 'BUY'

----------

JEFFERIES CUTS BELLWAY PRICE TARGET TO 3942 (4180) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

INVESTEC CUTS PREMIER OIL TO 'HOLD' ('BUY') - TARGET 25 (135) PENCE

----------

SHORE CAPITAL RESUMES HOLLYWOOD BOWL WITH 'BUY'

----------

LIBERUM RESUMES JOULES WITH 'BUY'

----------

JEFFERIES CUTS RESTAURANT GROUP PRICE TARGET TO 80 (170) PENCE - 'BUY'

----------

KEPLER CHEUVREUX CUTS HUNTING PRICE TARGET TO 230 (240) PENCE - 'HOLD'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.